NCT01702480 - Effects of Triglycerides on Age-Related Cognitive Function Decline in Older Subjects | Biotech Hunter

Enrollment

116

Participants

Timeline

Start Date

November 5, 2012

Primary Completion Date

July 3, 2015

Study Completion Date

July 3, 2015

Conditions

Alzheimer's Disease

Interventions

DRUG

GSK2981710

Will be available as 10 g medium-chain triglycerides (MCT) powder sachet that will be mixed with 125 - 250 milliliters (ml) water in a shaker and taken within 15 minutes of completion of breakfast

DRUG

Placebo

Will be available as matching powder that will be mixed with 125 - 250 milliliters (ml) water in a shaker and taken within 15 minutes of completion of breakfast

Trial Locations (1)

CB2 2GG

GSK Investigational Site, Cambridge